Holista Colltech Limited · ASX:HCT
Holista Colltech — Investor Presentation (April 2021)
30 slides from Holista Colltech's investor presentation, Apr 12, 2021
Slide 1: Investor Presentation April 2021
For personal use only Investor Presentation April 2021
Slide 2: Disclaimer
Disclaimer For personal use only This document has been prepared by Holista Colltech Limited and comprises written material/slides for a presentation concerning Holista Colltech Limited and its subsidiaries. The presentation is for information purposes only and does not constitute or form part of an
Slide 3: Company Overview (ASX: HCT)
Company Overview (ASX: HCT) World-leading technologies & global reach For personal use only Holista Colltech is an emerging Australian developer of unique • Global reach with customers in Asia, US and Australia health and wellness products in the • Successfully commercialised portfolio of patent- US
Slide 4: Investment Proposition
Investment Proposition Well-positioned for growth For personal use only Multiple growth avenues with defensive revenue streams Global reach with proven products sold around the world $ Large addressable and growing markets in health/wellness Well-funded to grow with cash holdings of ~$3m Positive 20
Slide 5: Business Division: Growth engines
Business Division Growth engines For personal use only • Fastest growing •Newest business •Largest •1st to produce Ovine Collagen Healthy Food Ingredients Infection Control Solutions Dietary Supplements division in FY20 (FY20 1st year sales/profit ovine collagen (sales +525%) contribution) contribut
Slide 6: Healthy Food Ingredients
For personal use only Healthy Food Ingredients Fast Growing and Underpenetrated Global Markets
Slide 7: Large & Growing Problem
Large & Growing Problem Diabetes & Obesity: the next pandemic with no vaccine For personal use only What is low GI? • Global obesity and weight loss market forecast to grow 7.1% CAGR (2019-2027)1 The Glycemic Index (GI) is a tool that • One-in-10 adults predicted to develop diabetes by measures how
Slide 8: Attractive Market Opportunity: GI Lite
Attractive Market Opportunity GI LiteTM filling an unmet need – healthy & same great taste For personal use only • Patented GI LiteTM is a Low GI-Certified, non-GMO, clean label (all-natural) premix • All ingredients sustainably harvested in natural conditions • Can be added to all white flour-based
Slide 9: Better Sugar Substitute: 80Less
Better Sugar Substitute 80LessTM extra sweet opportunity For personal use only • Low GI and low-calorie sugar substitute used in food manufacturing • Five times stronger than regular sugar and lowers calories by 80% • No artificial aftertaste and taste like sugar at all temperatures • Easy reformula
Slide 10: Unique Properties of 80Less
Unique Properties of 80LessTM Full Sugar Reduction Solution For personal use only Products using 80LessTM Unique ingredients that give 80LessTM use five times less sugar to its advantages over other sugar achieve the same level of substitutes sweetness • Sugar stevia (3D* balanced) • Sugar sucralose
Slide 11: Commercial Partnerships
Commercial Partnerships Global sales set to accelerate For personal use only Costanzo’s Bakery •A leading North American supplier of baked goods to major supermarkets •Signed 3-year agreement (Nov 2020) to buy minimum ~US$2m a year of GI LiteTM •GI LiteTM white breads to be sold at supermarket chain
Slide 12: Infection Control Solutions
For personal use only Infection Control Solutions Continued growth post COVID-19
Slide 13: NatShield and PathAway
NatShieldTM and PathAway® All-natural, gentle, effective and long lasting For personal use only NatShieldTM uses PathAway® as the active ingredient PathAway® is a plant-based, alcohol-free and non-toxic Independently tested to kill 99.9% of SARS-CoV-2 within two minutes Also effective against H1N1,
Slide 14: Partnership with GICC
Partnership with GICC Pathway to global markets For personal use only Global Infection Control Signed exclusive distribution rights for Consultants LLC (GICC) is a PathAway® to Asia, Oceania and South Carolina US-based Europe company that developed PathAway® and the M3® Forming a JV with GICC to Sys
Slide 15: M3 HVAC System Explained
M3® HVAC System Explained Controlling airborne viruses For personal use only M3® can be used in HVAC and fogging systems to disinfect indoor/outdoor areas M3® attaches easily to the central air-conditioning system of a building M3® dispenses botanical disinfectant (PathAway® or Bioesque*) into the v
Slide 16: Nasal Balm Development
Nasal Balm Development Protecting the nose - the weakest link to viruses For personal use only The nose is the most common entry point for viruses and bacteria (including the COVID-19 virus) to get into our cells • Patented balm that protects the nose for up to 12 hours • Made from all-natural ingre
Slide 17: US Sales Rebounding Strongly
US Sales Rebounding Strongly iGalen restructure and relaunch For personal use only iGalen is Holista’s global distribution partner iGalen Month-to-Month Sales (US$) • iGalen relaunched in August 2020 200,000 • Strong sales recovery with good margin driven by creative marketing and use of key influen
Slide 18: Solid Platform for Growth
Solid Platform for Growth Stronger sales expected in 2021 For personal use only 2021 Introduction of new ProtecteneTM nasal balm product FY2020 sales totalling $665k consisting Launch into of NatShieldTM hand sanitisers sold in government/enterprise market with M3® solution North America and Asia ou
Slide 19: Dietary Supplements
For personal use only Dietary Supplements Strong Cash Generator
Slide 20: Market Leader
Market Leader Healthy market dynamics For personal use only One of the largest supplements supplier in Malaysia with market leading brands Business generates ~70% of group revenue (FY20: $5.2m) Best selling and market leading products include LACTO-5® and Pristin® Launching pro immunity products inc
Slide 21: Improving Outlook
Improving Outlook Solid base to fund growth in other divisions For personal use only COVID-19 enhancing online sales Demand rebounding since start of 2021 (Q1 2021 growth ~30%) Improved sales expected as pandemic eases “Cash cow” division for the group Consumers’ continued focus on health & wellbein
Slide 22: Ovine (Sheep) Collagen
For personal use only Ovine (Sheep) Collagen Unlocking value in the business for shareholders
Slide 23: Unique Collagen Offering
Unique Collagen Offering Why Holista’s product is highly prized globally For personal use only • Australia is certified disease free by the US Department of Agriculture (USDA) • Disease free status is very important in medical grade collagen • The Company extracts collagen from sheepskins via patent
Slide 24: Unlocking Value
Unlocking Value Options under review For personal use only Upgrade Produce medical-grade collagen (market price ~A$540k per kg vs. cosmetic grade at ~A$75 Sustain per kg) to capitalise on Licence large new markets Continue to produce Develop food grade and market unique collagen and licence collagen
Slide 25: Outlook
For personal use only Outlook Roadmap to growth
Slide 26: Milestones: The next 12 months
Milestones The next 12-months For personal use only New immunity Costanzo’s to enhancing Completing launch world’s Launch nasal supplements – Launch of development lowest GI white balm and wipes Pristin® 80less™ cocoa of water bread using GI chewable milk soluble LiteTM omega-3 Vitamin D gummies Q2
Slide 27: Building Future Value
Building Future Value Next-generation of innovative products For personal use only Water Soluble Technology • Vitamin D • Water Soluble Turmeric and Cinnamon Nano Collagen Food Grade Collagen NatShield™ cannister sanitiser delivery Test-kits and mobile APPs (for track and trace) 27 Investor Presenta
Slide 28: The path forward
The path forward An improved FY21 outlook For personal use only Healthy Food Infection Control ✓ Trading conditions in start of FY21 showing marked improvement over GROWING • US sales growing via • Sales of sanitisers FY20 Costanzo’s expected to continue • Orders from Rex and to grow ✓ Global trends
Slide 29: Board of Directors & Advisors
Board of Directors & Advisors Expertise to lead the group forward For personal use only Daniel O’Connor Rajen Manicka Chan Heng Fai Blair Michelson Arthur Martin Roscoe Moore Non-Exec Chairman MD & CEO Non-Executive Director Non-Executive Director Advisor Advisor Over three decades in Dr Rajen spent
Slide 30: Thank You
For personal use only To join our mailing list please email: update@holistaco.com Thank You For further information, please contact: Corporate Matters: investor@holistaco.com General Enquiries: enquiries@holistaco.com Investor/Media Relations: Brendon Lau (m: 0409 341 613, e: brendon@vantagepointpar
Holista Colltech — Investor Presentation (April 2021) on 6ix